Literature DB >> 1637800

The dimensional approach to clinical psychopharmacology: a polysemous concept.

P Baruch1, M J Filteau, R H Bouchard, E Pourcher, P Vincent, R Jouvent.   

Abstract

The last decade has seen significant progress in the development and specific clinical application of selective psychotropes. The dimensional approach to clinical psychopharmacology views the behavioral targets of psychotropes as phenomena existing on a continuum and as components, in varying degrees, of most psychopathologies. The modern concept of dimension has been used in different contexts. In psychology it has a mathematical sense, whereas in biological psychiatry it is associated more with biological function. This paper reviews these two concepts and the recent models attempting to merge them into one. The heuristic value of the dimensional approach, as well as some of its pitfalls and new avenues of research, are discussed.

Mesh:

Substances:

Year:  1992        PMID: 1637800      PMCID: PMC1188401     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  21 in total

1.  Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders.

Authors:  H M Praag; J Korf; T Schut
Journal:  Psychol Med       Date:  1975-05       Impact factor: 7.723

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Evaluating the affective and cognitive effects of a drug: theoretical and methodological considerations.

Authors:  R Jouvent
Journal:  Arch Gerontol Geriatr Suppl       Date:  1989

4.  Biological suicide research: outcome and limitations.

Authors:  H M van Praag
Journal:  Biol Psychiatry       Date:  1986-11       Impact factor: 13.382

Review 5.  A psychobiological perspective on the personality disorders.

Authors:  L J Siever; K L Davis
Journal:  Am J Psychiatry       Date:  1991-12       Impact factor: 18.112

Review 6.  Advances in personality theory and research.

Authors:  R M Stelmack
Journal:  J Psychiatry Neurosci       Date:  1991-09       Impact factor: 6.186

Review 7.  The clinical utility of pharmacological agents that act at serotonin receptors.

Authors:  S J Peroutka; A J Sleight; B G McCarthy; P A Pierce; A W Schmidt; C R Hekmatpanah
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1989       Impact factor: 2.198

Review 8.  Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders.

Authors:  H M van Praag; R S Kahn; G M Asnis; S Wetzler; S L Brown; A Bleich; M L Korn
Journal:  J Affect Disord       Date:  1987 Jul-Aug       Impact factor: 4.839

Review 9.  The new generation of serotonergic anxiolytics: possible clinical roles.

Authors:  M S Eison
Journal:  Psychopathology       Date:  1989       Impact factor: 1.944

Review 10.  Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system.

Authors:  E C Azmitia; P M Whitaker-Azmitia
Journal:  J Clin Psychiatry       Date:  1991-12       Impact factor: 4.384

View more
  2 in total

1.  Symptoms, disorders and chemistry.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1992-09       Impact factor: 6.186

Review 2.  Inflammation-associated depression: from serotonin to kynurenine.

Authors:  Robert Dantzer; Jason C O'Connor; Marcus A Lawson; Keith W Kelley
Journal:  Psychoneuroendocrinology       Date:  2010-10-30       Impact factor: 4.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.